ICON PLC (ICLR) research

ICON PLC
ShareXLinkedInReddit
Sector
Healthcare
Industry
Diagnostics & Research
Last price
$167.11
As of

ICON PLC (ICLR): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-09.

As of . Source: SEC EDGAR filings for ICLR. Method and limitations.

SHARE THIS CARD

Share the ICLR intelligence card

A branded snapshot of ICLR: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion ICLR intelligence card preview
Post to X
LIVE TERMINAL

See ICLR live in the terminal

Track ICLR's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live ICLR terminal, free

Active signals for ICLR

FREE, NO ACCOUNT

Every signal on ICLR, as it fires

You are seeing 5 of 13 signals recorded on ICLR since 2026-06-03.

The five above landed across 3 days. The other 8 were recorded on 2 other days. 11 of the 13 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in ICLR (2026Q2)

Manager / securityMarket value% portfolioQoQ
GREENHAVEN ASSOCIATES INCCUSIP G4705A100 · 2026Q2$538.6M6.22%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, ICLR

ICLR against its peers

ICLR's operating margin of 5.4% ranks in the 82nd percentile of 18 Diagnostics & Research sub-industry peers, fiscal periods ending between 2025-06-30 and 2025-12-31.

MetricICLRPeer medianPercentilen
Revenue FY8.3B USD77.2M USD9819
Revenue YoY-0.4%n/an/a2
Gross marginn/a62.3%n/a13
Operating margin5.4%-17.6%8218
Net margin2.8%-20.6%7819
Return on equity2.5%-8.7%6816

Peers (21): TWST, QGEN, BLLN, CDNA, NEO, PSNL, OPK, BDSX, BNR, IMDX, FONR, QUCY, MDXH, PRPO, IDXG, LDDD, AWHL, MBAI, NDRA, XWEL, ISPC. Left out: ANPCF (no annual filing), PMDI (period gap), ADVB (no annual filing), BIAF (no annual filing). Fiscal periods ending between 2025-06-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (ICLR: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more ICLR signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ICLRand get the insider, 13F, options, and confluence read in one view.

Open the live ICLR terminal, free